Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2017
Jumping the Barrier: Modeling Drug Penetration across the Blood-Brain BarrierCody J Peer, Cindy H Chau, William D Figg
Cancer Biology & Therapy|March 11, 2015
Targeted PI3Kδ inhibition by the small molecule idelalisib as a novel therapy in indolent non-Hodgkin lymphomaTracy C Okoli, Cody J Peer, Kieron Dunleavy, et al.
Immunologic Research|September 17, 2009
Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermiaAdrienne J Peer, Melissa J Grimm, Evan R Zynda, et al.
Pharmacogenomics|November 8, 2016
Pharmacogenomics and histone deacetylase inhibitorsAndrew Kl Goey, Tristan M Sissung, Cody J Peer, et al.
Seminars in Oncology|October 25, 2023
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogeneticsYi Zeng, Oluwatobi Arisa, Cody J Peer, et al.
Cancer Biology & Therapy|November 21, 2013
The androgen receptor transcriptional program in castration-resistant prostate cancer: cell lines vs. tissue samplesJeffrey E Roth, Cody J Peer, Douglas K Price, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 9, 2012
Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorinCody J Peer, Terence J McManus, Herbert I Hurwitz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 16, 2018
A sensitive and rapid ultra high-performance liquid chromatography with tandem mass spectrometric assay for the simultaneous quantitation of cyclophosphamide and the 4-hydroxycyclophosphamide metabolite in human plasmaO Morgan Hall, Cody J Peer, Courtney D Fitzhugh, et al.
Pediatrics|July 9, 2020
Increasing Vaginal Chlamydia Trachomatis Testing in Adolescent and Young AdultsKathryn S Brigham, Michael J Peer, Brian B Ghoshhajra, et al.
Translational Oncology|May 6, 2022
Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironmentXianyu Zhang, Yunkai Yu, Cody J Peer, et al.
Pageof 16